What is Ukko?
Based out of Palo Alto, CA, Ukko operates at the intersection of artificial intelligence and biotechnology, specializing in developing innovative solutions for food sensitivities. The company leverages advanced AI algorithms to analyze complex biological data, aiming to provide personalized and effective approaches to managing dietary restrictions and improving consumer health. This focus positions Ukko as a key player in the rapidly expanding health-tech and personalized nutrition markets.
How much funding has Ukko raised?
Ukko has raised a total of $47.7M across 2 funding rounds:
Series A
$7.7M
Series B
$40M
Series A (2017): $7.7M with participation from Innovation Endeavors, Marc Benioff, Slow Ventures, Izhar Armony, and Khosla Ventures
Series B (2021): $40M led by Peak Bridge Ventures, Leaps by Bayer, Skyviews Life Science, Fall Line Capital, and Continental Grain Company
Key Investors in Ukko
Innovation Endeavors
Innovation Endeavors is a venture capital firm that invests in companies leveraging technology to address global challenges. Their focus often spans areas like AI, robotics, and sustainability.
Fall Line Capital
Fall Line Capital specializes in redefining investment in farmland and technology across the United States. They focus on purchasing and actively managing farmland while investing in technology that enhances their land holdings.
Continental Grain Company
CGC is a global investor, owner, and operator of companies across the food, agribusiness, and commodities spectrum. The company was founded in 1813 and is headquartered in New York City.
What's next for Ukko?
The recent major strategic investment signals a new phase of expansion for Ukko, likely enabling the company to accelerate its research and development efforts, scale its operations, and broaden its market reach. This capital infusion is expected to fuel further innovation in AI-driven diagnostics and therapeutic solutions for food sensitivities, solidifying Ukko's position as a leader in the biotechnology landscape. The company's strategic focus on leveraging AI for health solutions indicates a commitment to long-term growth and market disruption.
See full Ukko company page
